Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs and Secretomes for PCOS with Insulin Resistance
NCT05279768Phase 2Completed
- Sponsor
- Prodia Stem Cell Indonesia
- Start
- Sep 2022
- Primary completion
- Jan 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in polycystic ovary syndrome (PCOS), sponsored by Prodia Stem Cell Indonesia. Started Sep 2022; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05279768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05279768.